ALLMedicine™ Vitiligo Center

Sep 21st, 2020 - Vitiligo is an autoimmune skin disorder characterized by depigmented patches of the skin associated with, among several factors, dysregulation and death of melanocytes. Currently, the treatment of vitiligo is based both on the arrest of the progre...

Sep 19th, 2020 - Vitiligo is a typical pigmented skin disorder, which affects up to 1% of the global population, and the appearance of the patient is severely affected. Its lesions are often characterized by large affected areas, irregular shapes, low contrast, an...

Sep 19th, 2020 - Case of extensive scrotal calcinosis associated with vitiligo.|2020|Mai S,Dergamoun H,Senouci K,Benzekri L,|

Sep 18th, 2020 - Toll-like receptors (TLRs) are expressed on human melanocytes, and play an important role in innate and acquired immunity. The role of TLRs in the pathogenesis of vitiligo has not been fully described. To investigate the expression of TLRs in mela...

Sep 17th, 2020 - Exosomes are nanosized extracellular vesicles that originate from endosomes and are secreted by most cells into the extracellular space. They serve as mediators of intercellular communication and have been implicated in the regulation of several p...

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

Sep 21st, 2020 - Vitiligo is an autoimmune skin disorder characterized by depigmented patches of the skin associated with, among several factors, dysregulation and death of melanocytes. Currently, the treatment of vitiligo is based both on the arrest of the progre...

Sep 19th, 2020 - Vitiligo is a typical pigmented skin disorder, which affects up to 1% of the global population, and the appearance of the patient is severely affected. Its lesions are often characterized by large affected areas, irregular shapes, low contrast, an...

Sep 19th, 2020 - Case of extensive scrotal calcinosis associated with vitiligo.|2020|Mai S,Dergamoun H,Senouci K,Benzekri L,|

Sep 18th, 2020 - Toll-like receptors (TLRs) are expressed on human melanocytes, and play an important role in innate and acquired immunity. The role of TLRs in the pathogenesis of vitiligo has not been fully described. To investigate the expression of TLRs in mela...

Sep 17th, 2020 - Exosomes are nanosized extracellular vesicles that originate from endosomes and are secreted by most cells into the extracellular space. They serve as mediators of intercellular communication and have been implicated in the regulation of several p...

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

Feb 5th, 2020 - To the Editor: Pembrolizumab is an anti–programmed death receptor 1 humanized monoclonal antibody used for treating advanced or metastatic melanoma. 1 It is associated with several immune-related adverse events because it blocks a T-cell receptor c.

Feb 3rd, 2020 - A new line of Barbie dolls unveiled by Mattel earlier this month includes one with vitiligo, much to the delight of clinicians who treat children and adolescents with the condition. Mattel, Inc.

Oct 29th, 2019 - MADRID – Repigmentation in patients with vitiligo documented at 24 weeks continued to increase up to 1 year, in a randomized clinical trial of ruxolitinib cream for the treatment of vitiligo, Amit G. Pandya, MD, reported at the annual congress of.